Abacus Medicine Pharmaceuticals ApS: Financial statements 2020
CVR: 39192063
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -63,479 and a net result of DKK 188,314 compared with DKK 547,639 the year before. Equity in the 2020 report amounted to DKK 22,572,138. The solvency ratio was 38.6%.
- Gross Profit
- DKK -63,479
- Profit/Loss
- DKK 188,314
- Equity
- DKK 22,572,138
- Total Assets
- DKK 58,495,468
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -63K | 188K | 22.6M | 0 |
| 2019 | - | -212K | 548K | 15.9M | 0 |
| 2018 | - | -62K | 860K | 15.3M | - |
Official annual report
How creditworthy is Abacus Medicine Pharmaceuticals ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Abacus Medicine Pharmaceuticals ApS has published its annual report for 2019. Gross profit came to DKK -212,160, and the net result was DKK 547,639.
About Abacus Medicine Pharmaceuticals ApS
Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Abacus Medicine Pharma Services ApS and Aposave ApS. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity in the 2025 report amounted to DKK 14,264,000.